CAG
ABT icon

Csenge Advisory Group’s Abbott ABT Stock Holding History

Csenge Advisory Group’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
15,051
+739
+5% +$83.4K 0.07% 226
2025
Q4 		$1.79M Sell
14,312
-12,522
-47% -$1.6M 0.08% 197
2025
Q3 		$3.59M Buy
26,834
+7,949
+42% +$1.04M 0.17% 114
2025
Q2 		$2.52M Sell
18,885
-422
-2% -$55.6K 0.13% 130
2025
Q1 		$2.53M Buy
19,307
+3,356
+21% +$427K 0.14% 129
2024
Q4 		$1.8M Sell
15,951
-104
-0.6% -$12K 0.1% 164
2024
Q3 		$1.86M Sell
16,055
-483
-3% -$53K 0.1% 158
2024
Q2 		$1.72M Sell
16,538
-2,193
-12% -$233K 0.1% 156
2024
Q1 		$2.13M Buy
18,731
+1,182
+7% +$136K 0.12% 135
2023
Q4 		$1.93M Buy
17,549
+1,918
+12% +$192K 0.12% 149
2023
Q3 		$1.51M Sell
15,631
-1,099
-7% -$115K 0.1% 164
2023
Q2 		$1.82M Buy
16,730
+2,037
+14% +$217K 0.12% 133
2023
Q1 		$1.49M Buy
14,693
+957
+7% +$101K 0.11% 155
2022
Q4 		$1.51M Sell
13,736
-887
-6% -$91.8K 0.12% 157
2022
Q3 		$1.42M Buy
14,623
+430
+3% +$45.8K 0.12% 161
2022
Q2 		$1.54M Buy
14,193
+534
+4% +$60.6K 0.13% 153
2022
Q1 		$1.62M Buy
13,659
+3,561
+35% +$441K 0.13% 145
2021
Q4 		$1.18M Sell
10,098
-2,448
-20% -$313K 0.11% 167
2021
Q3 		$1.47M Buy
12,546
+2,448
+24% +$301K 0.12% 144
2021
Q2 		$1.18M Buy
10,098
+1,073
+12% +$125K 0.11% 167
2021
Q1 		$1.09M Sell
9,025
-357
-4% -$42.3K 0.11% 145
2020
Q4 		$1.03M Sell
9,382
-661
-7% -$71.8K 0.12% 130
2020
Q3 		$1.07M Buy
10,043
+1,073
+12% +$109K 0.15% 116
2020
Q2 		$820K Sell
8,970
-1,224
-12% -$111K 0.12% 140
2020
Q1 		$804K Buy
10,194
+2,945
+41% +$246K 0.21% 104
2019
Q4 		$630K Buy
7,249
+506
+8% +$42.4K 0.16% 125
2019
Q3 		$564K Sell
6,743
-1,713
-20% -$146K 0.15% 130
2019
Q2 		$711K Buy
+8,456
New +$666K 0.24% 77
2018
Q4 		– Sell
-449
Closed -$31K – 199
2018
Q3 		$31K Buy
+449
New +$29.5K 0.01% 331

Other funds holding ABT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Csenge Advisory Group's ABT Position: Q1 2026 in Review

Csenge Advisory Group increased its Abbott (ABT) stake by 5.2% in Q1 2026, buying an estimated $83.4K and bringing the position to 15,051 shares worth $1.55M. The position accounts for 0.07% of the portfolio, ranked #226.

Csenge Advisory Group first reported a position in ABT in Q3 2018 and has held it in 29 quarters since. The position peaked at $3.59M in Q3 2025. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Csenge Advisory Group held 15,051 shares of Abbott worth $1.55M as of Q1 2026.
  • Csenge Advisory Group bought 739 Abbott shares in Q1 2026, an estimated $83.4K.
  • Abbott made up 0.07% of Csenge Advisory Group's portfolio in Q1 2026, its #226 holding.
  • Csenge Advisory Group first reported a position in Abbott in Q3 2018 and has held it in 29 quarters since.
  • Csenge Advisory Group's Abbott position peaked at $3.59M in Q3 2025.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.